| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.03 |